Dr. Mary O’Connor is the co-founder and Chief Medical Officer of Vori Health, and she’s working to transform delivery of musculoskeletal care using a holistic, integrated approach.
In this short video, we talk about Vori, and hear from Dr. O’Connor about her background and how she sees Vori Health’s ability to make a huge impact.
Read More
Dr. Jennifer Potter, Professor of Psychiatry & Behavior Science, and VP for Research at UT Health San Antonio is working to overhaul the treatment approach and culture around substance use.
She’s on a mission to provide compassionate, evidence-based treatment using a rational and scientific approach to reduce morbidity and mortality, while increasing access and equity.
Read More
Dr. Besim Ogretmen of the Medical University of South Carolina recently discovered a Covid Biomarker through lipid research.
They discovered that a person’s level of lipid biomarker sphingosine had more than a 90% accuracy rate of determining if the person would have an asymptomatic or symptomatic case of covid-19.
In this interview Dr. Ogretmen shares information about his research, the discovery, as well as incredibly fascinating information about the field of Lipidomics – and how increased focus on the field could help transform medicine.
Read More
In this short video, we share our takeaways from our interview with Dr. Jennifer Potter, who is working to overhaul both the treatment and culture of substance-use disorders.
Dr. Potter is a Professor of Psychiatry & Behavior Science, and VP for Research at UT Health San Antonio.
Read More
In this short video, we talk about our highlights from this week’s interview with Dr. Besim Ogretmen of the Medical University of South Carolina.
Dr. Ogretmen typically focuses on cancer research, but during the covid-19 pandemic, he and his team pivoted their efforts.
They discovered a lipid biomarker that had more than a 90% accuracy rate of determining if someone would have an asymptomatic or symptomatic case of covid-19.
Read More
